InMode (INMD) Interest Expenses (2018 - 2025)
InMode (INMD) posted quarterly Interest Expenses of $4.8 million for Q4 2025, up 12.29% year-on-year from $4.2 million in Q4 2024, and up 12.29% on a QoQ basis from $4.2 million in Q4 2024.
InMode (INMD) Interest Expenses (2018 - 2025) Analysis & Trends
InMode (INMD) has reported Interest Expenses for 8 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.
- Quarterly Interest Expenses rose 12.29% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 12.29% YoY) and the FY2025 annual result came in at $139.6 million, up 0.68% from the prior year.
- Interest Expenses grew to $4.8 million in Q4 2025 per INMD's latest filing, from $4.2 million in the prior quarter.
- Over the last five years, Interest Expenses for INMD reached as high as $64.4 million in Q4 2023 and fell as low as -$270000.0 in Q4 2021.
- A 5-year average of $7.0 million and a median of $742000.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses tumbled 111.4% — and 2023, when it soared 8576.15%.
- Year by year, Interest Expenses stood at -$270000.0 in 2021, then soared by 374.81% to $742000.0 in 2022, then surged by 8576.15% to $64.4 million in 2023, then plunged by 93.4% to $4.2 million in 2024, then gained by 12.29% to $4.8 million in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $4.8 million, $4.2 million, and $64.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 3.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 96.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -140.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -97.17 Mn |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.77 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Dec 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 64.38 Mn |
| Dec 31, 2023 | 64.38 Mn |
| Dec 31, 2022 | 742,000.00 |
| Dec 31, 2022 | 742,000.00 |
| Sep 30, 2022 | 586,000.00 |
| Sep 30, 2022 | 586,000.00 |
| Jun 30, 2022 | 851,000.00 |
| Jun 30, 2022 | 851,000.00 |
| Mar 31, 2022 | 90,000.00 |
| Mar 31, 2022 | 90,000.00 |
| Dec 31, 2021 | -270,000.00 |
| Dec 31, 2021 | -270,000.00 |
| Sep 30, 2021 | 789,000.00 |
| Sep 30, 2021 | 789,000.00 |
| Jun 30, 2021 | 404,000.00 |
| Jun 30, 2021 | 404,000.00 |